Search Results - "O'SHAUGHNESSY, Michael V"

Refine Results
  1. 1

    Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients by Côté, Hélène C.F, Brumme, Zabrina L, Craib, Kevin J.P, Alexander, Christopher S, Wynhoven, Brian, Ting, Lillian, Wong, Hubert, Harris, Marianne, Harrigan, P. Richard, O'Shaughnessy, Michael V, Montaner, Julio S.G

    Published in The New England journal of medicine (14-03-2002)
    “…This study analyzed changes in mitochondrial DNA relative to nuclear DNA in the peripheral-blood cells of patients infected with the human immunodeficiency…”
    Get full text
    Journal Article
  2. 2

    Prevalence and Correlates of Untreated Human Immunodeficiency Virus Type 1 Infection among Persons Who Have Died in the Era of Modern Antiretroviral Therapy by Wood, Evan, Montaner, Julio S. G., Tyndall, Mark W., Schechter, Martin T., O’Shaughnessy, Michael V., Hogg, Robert S.

    Published in The Journal of infectious diseases (15-10-2003)
    “…We evaluated all human immunodeficiency virus (HIV)–related deaths over the period 1 January 1995–31 December 2001 in a Canadian province in which all HIV care…”
    Get full text
    Journal Article
  3. 3

    Sexual violence among a cohort of injection drug users by Braitstein, Paula, Li, Kathy, Tyndall, Mark, Spittal, Patricia, O'Shaughnessy, Michael V, Schilder, Arn, Johnston, Caitlin, Hogg, Robert S, Schechter, Martin T

    Published in Social science & medicine (1982) (01-08-2003)
    “…The objective of this study was to determine the prevalence of, and factors associated with, sexual violence in childhood, adolescence and adulthood, among…”
    Get full text
    Journal Article
  4. 4

    “Being dealt with as a whole person.” Care seeking and adherence: the benefits of culturally competent care by Schilder, Arn J, Kennedy, Cornelis, Goldstone, Irene L, Ogden, Russel D, Hogg, Robert S, O’Shaughnessy, Michael V

    Published in Social science & medicine (1982) (01-06-2001)
    “…The purpose of this study is to characterize the relationship between identity and health care experiences (including antiretroviral therapy utilization) among…”
    Get full text
    Journal Article
  5. 5

    Impact of HIV Infection on Mortality in a Cohort of Injection Drug Users by Tyndall, Mark W, Craib, Kevin J. P, Currie, Sue, Li, Kathy, OʼShaughnessy, Michael V, Schechter, Martin T

    “…The prevalence of HIV has been rising among injection drug users (IDUs) and AIDS is now an important cause of death among that population. We tracked mortality…”
    Get full text
    Journal Article
  6. 6

    Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response by BRUMME, Zabrina L, DONG, Winnie W. Y, CHAN, Keith J, HOGG, Robert S, MONTANER, Julio S. G, O'SHAUGHNESSY, Michael V, HARRIGAN, P. Richard

    Published in AIDS (London) (24-01-2003)
    “…Single nucleotide polymorphisms (SNP) in the genes encoding the human CX3CR1 chemokine receptor and the P-glycoprotein multidrug transporter have been…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Higher Baseline Levels of Plasma Human Immunodeficiency Virus Type 1 RNA Are Associated with Increased Mortality after Initiation of Triple-Drug Antiretroviral Therapy by Wood, Evan, Hogg, Robert S., Yip, Benita, Quercia, Romina, Harrigan, P. Richard, O’Shaughnessy, Michael V., Montaner, Julio S. G.

    Published in The Journal of infectious diseases (15-11-2003)
    “…We evaluated 1422 antiretroviral therapy (ART)–naive patients infected with human immunodeficiency virus (HIV) who initiated highly active antiretroviral…”
    Get full text
    Journal Article
  9. 9

    Requiring Help Injecting as a Risk Factor for HIV Infection in the Vancouver Epidemic: Implications for HIV Prevention by Wood, Evan, Spittal, Patricia M., Kerr, Thomas, Small, Will, Tyndall, Mark W., O'Shaughnessy, Michael V., Schechter, Martin T.

    Published in Canadian journal of public health (01-09-2003)
    “…Background: Requiring help injecting was recently associated with syringe sharing, and later HIV-1 and HCV seroconversion among injection drug users (IDU) in…”
    Get full text
    Journal Article
  10. 10

    Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy by Palepu, Anita, Tyndall, Mark W, Li, Kathy, Yip, Benita, O'Shaughnessy, Michael V, Schechter, Martin T, Montaner, Julio S G, Hogg, Robert S

    Published in Journal of urban health (01-12-2003)
    “…We conducted this study among HIV-infected injection drug users to determine the effect of self-reported alcohol use and prior incarceration at the time of…”
    Get full text
    Journal Article
  11. 11

    Antiretroviral Concentrations in Untimed Plasma Samples Predict Therapy Outcome in a Population with Advanced Disease by Alexander, Christopher S., Asselin, Jérôme J., Ting, Lillian S. L., Montaner, Julio S. G., Hogg, Robert S., Yip, Benita, O'Shaughnessy, Michael V., Harrigan, P. Richard

    Published in The Journal of infectious diseases (15-08-2003)
    “…This study was designed to examine the relationship between untimed antiretroviral concentrations measured in plasma samples collected for virus-load testing…”
    Get full text
    Journal Article
  12. 12

    Satellite Needle Distribution Among Injection Drug Users: Policy and Practice in Two Canadian Cities by Tyndall, Mark W, Bruneau, Julie, Brogly, Susan, Spittal, Patricia, OʼShaughnessy, Michael V, Schechter, Martin T

    “…Access to clean needles and syringes through needle exchange programs (NEPs) has reduced both high-risk behaviors and the transmission of blood-borne…”
    Get full text
    Journal Article
  13. 13

    Incidence of morphological and lipid abnormalities: gender and treatment differentials after initiation of first antiretroviral therapy by Heath, Katherine V, Chan, Keith J, Singer, Joel, O’Shaughnessy, Michael V, Montaner, Julio S G, Hogg, Robert S

    Published in International journal of epidemiology (01-10-2002)
    “…Objective To provide population-based incidence estimates for constituent symptoms of human immundeficiency virus (HIV)-related lipodystrophy syndrome and to…”
    Get full text
    Journal Article
  14. 14

    Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L by Wood, Evan, Hogg, Robert S, Yip, Benita, Harrigan, P Richard, O'Shaughnessy, Michael V, Montaner, Julio S G

    Published in Annals of internal medicine (18-11-2003)
    “…The safety of delaying highly active antiretroviral therapy (HAART) in HIV-infected patients is uncertain when the CD4+ cell count declines below 0.350 x 10(9)…”
    Get full text
    Journal Article
  15. 15

    Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy by Hogg, Robert S, Yip, Benita, Chan, Keith J, Wood, Evan, Craib, Kevin J. P, O'Shaughnessy, Michael V, Montaner, Julio S. G

    “…CONTEXT Current recommendations for initiation of antiretroviral therapy in patients infected with human immunodeficiency virus type 1 (HIV) are based on CD4…”
    Get full text
    Journal Article
  16. 16

    Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic by TYNDALL, Mark W, CURRIE, Sue, SPITTAL, Patricia, LI, Kathy, WOOD, Evan, O'SHAUGHNESSY, Michael V, SCHECHTER, Martin T

    Published in AIDS (London) (11-04-2003)
    “…The explosive and ongoing injecting drug use-related HIV-1 epidemic in Vancouver continues to receive international attention. This study was conducted to…”
    Get full text
    Journal Article
  17. 17

    Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up by HOGG, Robert S, HEATH, Katherine, BANGSBERG, David, YIP, Benita, PRESS, Natasha, O'SHAUGHNESSY, Michael V, MONTANER, Julio S. G

    Published in AIDS (London) (03-05-2002)
    “…To characterize the impact of intermittent use of triple drug antiretroviral therapy on survival. Population-based analysis of 1282 antiretroviral therapy…”
    Get full text
    Journal Article
  18. 18

    The end of the line: has rapid transit contributed to the spatial diffusion of HIV in one of Canada’s largest metropolitan areas? by Wood, Evan, Chan, Keith, Montaner, Julio S.G, Schechter, Martin T, Tyndall, Mark, O’Shaughnessy, Michael V, Hogg, Robert S

    Published in Social science & medicine (1982) (01-09-2000)
    “…The objective of this study is to describe the relationship between socio-demographic characteristics and the geographic distribution of persons with HIV in…”
    Get full text
    Journal Article
  19. 19

    Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users by Wood, Evan, Montaner, Julio S G, Yip, Benita, Tyndall, Mark W, Schechter, Martin T, O'Shaughnessy, Michael V, Hogg, Robert S

    “…The benefits of highly active antiretroviral therapy (HAART) for the treatment of HIV infection are well documented, but concerns regarding access and…”
    Get full text
    Journal Article
  20. 20

    Rates of Disease Progression among Human Immunodeficiency Virus-Infected Persons Initiating Multiple-Drug Rescue Therapy by Lee, Nelson, Hogg, Robert S., Yip, Benita, Harrigan, P. Richard, Harris, Marianne, O'Shaughnessy, Michael V., Montaner, Julio S. G.

    Published in The Journal of infectious diseases (01-07-2003)
    “…To characterize survival and to compare rates of disease progression to death of human immunodeficiency virus (HIV)-infected patients, between those initiating…”
    Get full text
    Journal Article